Lexaria Bioscience Ownership 2024 | Who Owns Lexaria Bioscience Now?

Overview RevenueFinancials Chart

Institutional Ownership

2.18%

Insider Ownership

7.76%

Retail Ownership

90.06%

Institutional Holders

13.00

Lexaria Bioscience Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ARMISTICE CAPITAL, LLC	7.36%	0.04%	1,020,000	1,020,000	100.00%	2,835,600	Jun 30, 2024
INVENOMIC CAPITAL MANAGEMENT LP	3.71%	0.07%	513,573	40,308	8.52%	1,427,733	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.83%	-	114,783	15,445	15.55%	319,193	Jun 30, 2024
VANGUARD GROUP INC	0.68%	-	93,586	8,430	9.90%	260,169	Jun 30, 2024
RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC.	0.45%	0.00%	48,800	9,250	23.39%	135,664	Jun 30, 2024
GENTRUST, LLC	0.43%	0.01%	60,000	60,000	100.00%	166,800	Jun 30, 2024
STATE STREET CORP	0.28%	-	39,301	-	-	109,257,000	Jun 30, 2024
BLACKROCK INC.	0.20%	-	27,445	25,937	1719.96%	76,297	Jun 30, 2024
WELCH GROUP, LLC	0.17%	0.00%	24,000	-	-	66,720	Jun 30, 2024
MORGAN STANLEY	0.17%	-	22,982	-372	-1.59%	63,890	Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC	0.16%	0.00%	22,800	22,800	100.00%	63,384	Jun 30, 2024
NORTHERN TRUST CORP	0.13%	-	18,389	-	-	51,121,000	Jun 30, 2024
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC	0.10%	0.00%	13,823	3,500	33.90%	38,428	Jun 30, 2024
XTX TOPCO LTD	0.09%	0.00%	12,602	2,326	22.64%	35,034	Jun 30, 2024
ROYAL BANK OF CANADA	0.05%	-	7,283	-	-	20,000	Jun 30, 2024
OAKWORTH CAPITAL, INC.	0.04%	0.00%	5,000	-	-	13,900	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.02%	0.00%	3,370	668	24.72%	9,369	Jun 30, 2024
WELLS FARGO & COMPANY/MN	0.02%	-	3,300	2,227	207.55%	9,174	Jun 30, 2024
1832 ASSET MANAGEMENT L.P.	0.02%	-	2,686	-	-	7,467	Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.	0.02%	-	2,290	100	4.57%	6,366	Jun 30, 2024

Lexaria Bioscience's largest institutional shareholder is ARMISTICE CAPITAL, LLC, holding 7.36% of the company's total share outstanding, currently valued at $2.84M. The top 10 institutional shareholders own together 14.28% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
INVENOMIC CAPITAL MANAGEMENT LP	3.71%	0.07%	513,573	40,308	8.52%	1,427,733	Jun 30, 2024
ARMISTICE CAPITAL, LLC	7.36%	0.04%	1,020,000	1,020,000	100.00%	2,835,600	Jun 30, 2024
GENTRUST, LLC	0.43%	0.01%	60,000	60,000	100.00%	166,800	Jun 30, 2024
WELCH GROUP, LLC	0.17%	0.00%	24,000	-	-	66,720	Jun 30, 2024
XTX TOPCO LTD	0.09%	0.00%	12,602	2,326	22.64%	35,034	Jun 30, 2024
OAKWORTH CAPITAL, INC.	0.04%	0.00%	5,000	-	-	13,900	Jun 30, 2024
ADAR1 CAPITAL MANAGEMENT, LLC	0.01%	0.00%	945	-25,681	-96.45%	2,627	Jun 30, 2024
ASPIRE PRIVATE CAPITAL, LLC	0.00%	0.00%	400	-	-	1,112	Jun 30, 2024
RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC.	0.45%	0.00%	48,800	9,250	23.39%	135,664	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.02%	0.00%	3,370	668	24.72%	9,369	Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC	0.16%	0.00%	22,800	22,800	100.00%	63,384	Jun 30, 2024
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC	0.10%	0.00%	13,823	3,500	33.90%	38,428	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.83%	-	114,783	15,445	15.55%	319,193	Jun 30, 2024
FARTHER FINANCE ADVISORS, LLC	0.00%	-	166	-	-	458	Jun 30, 2024
GABLES CAPITAL MANAGEMENT INC.	0.00%	-	13	-	-	36	Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.	0.02%	-	2,290	100	4.57%	6,366	Jun 30, 2024
NORTHERN TRUST CORP	0.13%	-	18,389	-	-	51,121,000	Jun 30, 2024
1832 ASSET MANAGEMENT L.P.	0.02%	-	2,686	-	-	7,467	Jun 30, 2024
VANGUARD GROUP INC	0.68%	-	93,586	8,430	9.90%	260,169	Jun 30, 2024
MORGAN STANLEY	0.17%	-	22,982	-372	-1.59%	63,890	Jun 30, 2024

The largest Lexaria Bioscience shareholder by % of total assets is INVENOMIC CAPITAL MANAGEMENT LP. The company owns 513.57K shares of Lexaria Bioscience (LEXX), representing 0.07% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ARMISTICE CAPITAL, LLC	7.36%	0.04%	1,020,000	1,020,000	100.00%	2,835,600	Jun 30, 2024
GENTRUST, LLC	0.43%	0.01%	60,000	60,000	100.00%	166,800	Jun 30, 2024
INVENOMIC CAPITAL MANAGEMENT LP	3.71%	0.07%	513,573	40,308	8.52%	1,427,733	Jun 30, 2024
BLACKROCK INC.	0.20%	-	27,445	25,937	1719.96%	76,297	Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC	0.16%	0.00%	22,800	22,800	100.00%	63,384	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.83%	-	114,783	15,445	15.55%	319,193	Jun 30, 2024
RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC.	0.45%	0.00%	48,800	9,250	23.39%	135,664	Jun 30, 2024
VANGUARD GROUP INC	0.68%	-	93,586	8,430	9.90%	260,169	Jun 30, 2024
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC	0.10%	0.00%	13,823	3,500	33.90%	38,428	Jun 30, 2024
XTX TOPCO LTD	0.09%	0.00%	12,602	2,326	22.64%	35,034	Jun 30, 2024
WELLS FARGO & COMPANY/MN	0.02%	-	3,300	2,227	207.55%	9,174	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.02%	0.00%	3,370	668	24.72%	9,369	Jun 30, 2024
MATHER GROUP, LLC.	0.00%	-	100	100	100.00%	363	Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.	0.02%	-	2,290	100	4.57%	6,366	Jun 30, 2024
TORONTO DOMINION BANK	0.00%	-	13	-	-	36	Jun 30, 2024
ALLWORTH FINANCIAL LP	0.00%	-	89	-	-	243	Jun 30, 2024
ROYAL BANK OF CANADA	0.05%	-	7,283	-	-	20,000	Jun 30, 2024
STATE STREET CORP	0.28%	-	39,301	-	-	109,257,000	Jun 30, 2024
1832 ASSET MANAGEMENT L.P.	0.02%	-	2,686	-	-	7,467	Jun 30, 2024
NORTHERN TRUST CORP	0.13%	-	18,389	-	-	51,121,000	Jun 30, 2024

As of Jun 30 2024, Lexaria Bioscience's largest institutional buyer is ARMISTICE CAPITAL, LLC. The company purchased 1.02M stocks of LEXX, valued at $2.84M.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ADAR1 CAPITAL MANAGEMENT, LLC	0.01%	0.00%	945	-25,681	-96.45%	2,627	Jun 30, 2024
MORGAN STANLEY	0.17%	-	22,982	-372	-1.59%	63,890	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.00%	-	96	-141	-59.49%	267	Jun 30, 2024
WELCH GROUP, LLC	0.17%	0.00%	24,000	-	-	66,720	Jun 30, 2024
OAKWORTH CAPITAL, INC.	0.04%	0.00%	5,000	-	-	13,900	Jun 30, 2024
ASPIRE PRIVATE CAPITAL, LLC	0.00%	0.00%	400	-	-	1,112	Jun 30, 2024
FARTHER FINANCE ADVISORS, LLC	0.00%	-	166	-	-	458	Jun 30, 2024
GABLES CAPITAL MANAGEMENT INC.	0.00%	-	13	-	-	36	Jun 30, 2024
NORTHERN TRUST CORP	0.13%	-	18,389	-	-	51,121,000	Jun 30, 2024
1832 ASSET MANAGEMENT L.P.	0.02%	-	2,686	-	-	7,467	Jun 30, 2024
STATE STREET CORP	0.28%	-	39,301	-	-	109,257,000	Jun 30, 2024
ROYAL BANK OF CANADA	0.05%	-	7,283	-	-	20,000	Jun 30, 2024
ALLWORTH FINANCIAL LP	0.00%	-	89	-	-	243	Jun 30, 2024
TORONTO DOMINION BANK	0.00%	-	13	-	-	36	Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.	0.02%	-	2,290	100	4.57%	6,366	Jun 30, 2024
MATHER GROUP, LLC.	0.00%	-	100	100	100.00%	363	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.02%	0.00%	3,370	668	24.72%	9,369	Jun 30, 2024
WELLS FARGO & COMPANY/MN	0.02%	-	3,300	2,227	207.55%	9,174	Jun 30, 2024
XTX TOPCO LTD	0.09%	0.00%	12,602	2,326	22.64%	35,034	Jun 30, 2024
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC	0.10%	0.00%	13,823	3,500	33.90%	38,428	Jun 30, 2024

As of Jun 30 2024, Lexaria Bioscience's biggest institutional seller is ADAR1 CAPITAL MANAGEMENT, LLC. The company sold -25.68K shares of LEXX, valued at $2.63K.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ARMISTICE CAPITAL, LLC	7.36%	0.04%	1,020,000	1,020,000	100.00%	2,835,600	Jun 30, 2024
GENTRUST, LLC	0.43%	0.01%	60,000	60,000	100.00%	166,800	Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC	0.16%	0.00%	22,800	22,800	100.00%	63,384	Jun 30, 2024
MATHER GROUP, LLC.	0.00%	-	100	100	100.00%	363	Jun 30, 2024

Lexaria Bioscience's largest new institutional shareholder by number of shares is ARMISTICE CAPITAL, LLC, purchased 1.02M shares, valued at $2.84M, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date

Lexaria Bioscience Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
NORTHERN LIGHTS FUND TRUST II	0.05%	518,209	-137,216	-20.94%	Jan 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	56,961	3,464	6.48%	Feb 29, 2024
VANGUARD INDEX FUNDS	0.00%	85,156	-7,326	-7.92%	Mar 31, 2024
DFA INVESTMENT DIMENSIONS GROUP INC	0.00%	11,196	-	-	Jan 31, 2024
Dimensional ETF Trust	0.00%	4,072	-	-	Jan 31, 2024

Lexaria Bioscience's largest mutual fund holder by % of total assets is "NORTHERN LIGHTS FUND TRUST II", owning 518.21K shares, compromising 0.05% of its total assets.

Lexaria Bioscience Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Jun, 24	13	-48.00%
31 Mar, 24	25	31.58%
31 Dec, 23	19	35.71%
30 Sep, 23	14	16.67%
30 Jun, 23	12	-25.00%
31 Mar, 23	16	-
31 Dec, 22	16	6.67%
30 Sep, 22	15	-
30 Jun, 22	15	36.36%
31 Mar, 22	11	-
31 Dec, 21	11	22.22%
30 Sep, 21	9	-
30 Jun, 21	9	28.57%
31 Mar, 21	7	-

As of 30 Jun 24, 13 institutions are holding Lexaria Bioscience's shares, representing a decrease of -48.00% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Jun, 24	302,576	-65.96%
31 Mar, 24	888,794	-25.66%
31 Dec, 23	1,195,589	-32.50%
30 Sep, 23	1,771,138	98.50%
30 Jun, 23	892,281	31.38%
31 Mar, 23	679,147	-2.57%
31 Dec, 22	697,092	1.37%
30 Sep, 22	687,645	22.42%
30 Jun, 22	561,720	18.85%
31 Mar, 22	472,634	3.32%
31 Dec, 21	457,456	1.21%
30 Sep, 21	451,978	8.29%
30 Jun, 21	417,364	31.23%
31 Mar, 21	318,051	-

Lexaria Bioscience (LEXX) has 302.58K shares outstanding as of 30 Jun 24, down -65.96% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Jun, 24	2.18%	3.20%
31 Mar, 24	8.26%	4.73%
31 Dec, 23	13.21%	1.84%
30 Sep, 23	26.78%	13.95%
30 Jun, 23	13.85%	10.64%
31 Mar, 23	11.41%	8.32%
31 Dec, 22	11.71%	8.58%
30 Sep, 22	11.68%	13.11%
30 Jun, 22	9.44%	14.76%
31 Mar, 22	8.00%	12.53%
31 Dec, 21	7.99%	7.54%
30 Sep, 21	10.29%	15.39%
30 Jun, 21	8.18%	13.28%
31 Mar, 21	7.85%	-

As of 30 Jun 24, Lexaria Bioscience is held by 2.18% institutional shareholders, representing a 3.20% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Jun, 24	7	-56.25%
31 Mar, 24	16	60.00%
31 Dec, 23	10	66.67%
30 Sep, 23	6	100.00%
30 Jun, 23	3	-25.00%
31 Mar, 23	4	-42.86%
31 Dec, 22	7	-
30 Sep, 22	7	-22.22%
30 Jun, 22	9	80.00%
31 Mar, 22	5	-28.57%
31 Dec, 21	7	16.67%
30 Sep, 21	6	-
30 Jun, 21	6	-14.29%
31 Mar, 21	7	-

7 institutional shareholders have increased their position in LEXX stock as of 30 Jun 24 compared to 16 in the previous quarter (a -56.25% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Jun, 24	-	-100.00%
31 Mar, 24	3	-25.00%
31 Dec, 23	4	-
30 Sep, 23	4	33.33%
30 Jun, 23	3	-
31 Mar, 23	3	-40.00%
31 Dec, 22	5	-
30 Sep, 22	5	400.00%
30 Jun, 22	1	-
31 Mar, 22	1	-
31 Dec, 21	-	-100.00%
30 Sep, 21	1	-
30 Jun, 21	1	-
31 Mar, 21	-	-

- institutional shareholders have reduced their position in LEXX stock as of 30 Jun 24 compared to 3 in the previous quarter (a -100.00% decrease).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Jun, 24	13	-48.00%	302,576	-65.96%	2.18%	3.20%	7	-56.25%	-	-100.00%
31 Mar, 24	25	31.58%	888,794	-25.66%	8.26%	4.73%	16	60.00%	3	-25.00%
31 Dec, 23	19	35.71%	1,195,589	-32.50%	13.21%	1.84%	10	66.67%	4	-
30 Sep, 23	14	16.67%	1,771,138	98.50%	26.78%	13.95%	6	100.00%	4	33.33%
30 Jun, 23	12	-25.00%	892,281	31.38%	13.85%	10.64%	3	-25.00%	3	-
31 Mar, 23	16	-	679,147	-2.57%	11.41%	8.32%	4	-42.86%	3	-40.00%
31 Dec, 22	16	6.67%	697,092	1.37%	11.71%	8.58%	7	-	5	-
30 Sep, 22	15	-	687,645	22.42%	11.68%	13.11%	7	-22.22%	5	400.00%
30 Jun, 22	15	36.36%	561,720	18.85%	9.44%	14.76%	9	80.00%	1	-
31 Mar, 22	11	-	472,634	3.32%	8.00%	12.53%	5	-28.57%	1	-
31 Dec, 21	11	22.22%	457,456	1.21%	7.99%	7.54%	7	16.67%	-	-100.00%
30 Sep, 21	9	-	451,978	8.29%	10.29%	15.39%	6	-	1	-
30 Jun, 21	9	28.57%	417,364	31.23%	8.18%	13.28%	6	-14.29%	1	-
31 Mar, 21	7	-	318,051	-	7.85%	-	7	-	-	-

Lexaria Bioscience Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Aug 13, 2024	TURKEL CATHERINE C.	director	-	P-Purchase	Buy	1,600	$3.13	$5.01K	3,100
Aug 01, 2024	Carle Vanessa	officer	Secretary	S-Sale	Sell	2,567	$4.00	$10.27K	-

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Aug 13, 2024	TURKEL CATHERINE C.	director	-	P-Purchase	Buy	1,600	$3.13	$5.01K	3,100

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Aug 01, 2024	Carle Vanessa	officer	Secretary	S-Sale	Sell	2,567	$4.00	$10.27K	-
May 15, 2024	Carle Vanessa	officer	Secretary	M-Exempt	Sell	2,500	$1.15	$2.88K	60,067
Mar 15, 2024	Cabatuan Nelson	officer	Chief Financial Officer		Sell	200,000	$2.93	$586.00K	-

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Aug 13, 2024	TURKEL CATHERINE C.	director	-	P-Purchase	Buy	1,600	$3.13	$5.01K	3,100
Aug 01, 2024	Carle Vanessa	officer	Secretary	S-Sale	Sell	2,567	$4.00	$10.27K	-
Jul 30, 2024	REESE ALBERT L JR	director	-	A-Award	Buy	12,000	$3.39	$40.68K	32,000
Jul 30, 2024	TURKEL CATHERINE C.	director	-	A-Award	Buy	12,000	$3.39	$40.68K	27,000
Jul 30, 2024	Baxter Nicholas W	director	-	A-Award	Buy	12,000	$3.39	$40.68K	52,000
Jul 30, 2024	McKechnie William Edward	director	-	A-Award	Buy	12,000	$3.39	$40.68K	52,000
May 15, 2024	Carle Vanessa	officer	Secretary	M-Exempt	Sell	2,500	$1.15	$2.88K	60,067
May 15, 2024	Carle Vanessa	officer	Secretary	M-Exempt	Buy	2,500	$1.15	$2.88K	2,567
May 10, 2024	Carle Vanessa	officer	Secretary	A-Award	Buy	10,000	$2.36	$23.60K	62,567
May 10, 2024	TURKEL CATHERINE C.	director	-	A-Award	Buy	5,000	$2.36	$11.80K	15,000
May 10, 2024	Baxter Nicholas W	director	-	A-Award	Buy	5,000	$2.36	$11.80K	40,000
May 10, 2024	McKechnie William Edward	director	-	A-Award	Buy	5,000	$2.36	$11.80K	40,000
May 10, 2024	REESE ALBERT L JR	director	-	A-Award	Buy	5,000	$2.36	$11.80K	20,000
May 10, 2024	BUNKA CHRISTOPHER	director, officer	Chief Executive Officer	A-Award	Buy	49,500	$2.36	$116.82K	180,501
May 10, 2024	DOCHERTY JOHN MARTIN	director, officer	President	A-Award	Buy	49,500	$2.36	$116.82K	174,168
Mar 15, 2024	Cabatuan Nelson	officer	Chief Financial Officer		Sell	200,000	$2.93	$586.00K	-
Nov 01, 2023	Carle Vanessa	officer	Secretary	A-Award	Buy	12,500	$1.15	$14.37K	52,567
Oct 30, 2023	DOCHERTY JOHN MARTIN	director, officer	President	A-Award	Buy	30,000	$1.15	$34.50K	124,668
Oct 30, 2023	BUNKA CHRISTOPHER	director, officer	Chief Executive Officer	A-Award	Buy	30,000	$1.15	$34.50K	131,001
Jul 25, 2023	Baxter Nicholas W	director	-	A-Award	Buy	5,000	$0.87	$4.35K	35,000

The last insider sell of Lexaria Bioscience's stock was made by Carle Vanessa on Aug 01 2024, selling 2,567 shares at $4.00 per share (valued at $10.27K). The last insider buy of LEXX was made by TURKEL CATHERINE C. on Aug 13 2024, buying 1,600 shares at $3.13 per share (worth $5.01K).

Lexaria Bioscience Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q3 2024	5	1	500.00%
Q2 2024	8	1	800.00%
Q1 2024	-	1	-
Q4 2023	3	-	-
Q3 2023	4	-	-
Q2 2023	-	1	-
Q1 2023	1	-	-
Q4 2022	10	-	-
Q3 2022	5	-	-
Q2 2022	4	-	-
Q1 2022	4	-	-
Q3 2021	6	-	-
Q2 2021	12	8	150.00%
Q1 2021	1	1	100.00%
Q4 2020	10	-	-
Q3 2020	1	1	100.00%
Q2 2020	8	2	400.00%
Q1 2020	1	8	12.50%
Q4 2019	2	2	100.00%
Q3 2019	1	-	-

5 total buy trades, and 1 total sell trades (buy/sell ratio of 5.00%) were made by Lexaria Bioscience's insiders, as of Q3 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q3 2024	1	1	100.00%
Q2 2024	-	-	-
Q1 2024	-	-	-
Q4 2023	-	-	-
Q3 2023	-	-	-
Q2 2023	-	-	-
Q1 2023	1	-	-
Q4 2022	3	-	-
Q3 2022	-	-	-
Q2 2022	-	-	-
Q1 2022	-	-	-
Q3 2021	-	-	-
Q2 2021	-	-	-
Q1 2021	-	-	-
Q4 2020	10	-	-
Q3 2020	-	-	-
Q2 2020	-	-	-
Q1 2020	-	-	-
Q4 2019	-	-	-
Q3 2019	-	-	-

As of Q3 2024, Insider owners conducted 1 open market buy trades and 1 open market sell trades of Lexaria Bioscience's stocks.

Lexaria Bioscience Peer Ownership

Ticker	Company
ZVSA	ZyVersa Therapeutics, Inc.
BDRX	Biodexa Pharmaceuticals Plc
CNSP	CNS Pharmaceuticals, Inc.
ONCR	Oncorus, Inc.
VIRI	Virios Therapeutics, Inc.
ICU	SeaStar Medical Holding Corporation
PHIO	Phio Pharmaceuticals Corp.
REVB	Revelation Biosciences, Inc.
RNAZ	TransCode Therapeutics, Inc.
EFTR	eFFECTOR Therapeutics, Inc.
IMMX	Immix Biopharma, Inc.
SONN	Sonnet BioTherapeutics Holdings, Inc.
ZURA	Zura Bio Limited

LEXX Ownership FAQ

Who Owns Lexaria Bioscience?

Lexaria Bioscience is owned by institutional shareholders (2.18%), insiders (7.76%), and public (90.06%). The largest institutional shareholder of Lexaria Bioscience is ARMISTICE CAPITAL, LLC (7.36% of total shares) and the top mutual fund owner is NORTHERN LIGHTS FUND TRUST II (0.05% of total shares).

Who are the major institutional shareholders of Lexaria Bioscience?

Lexaria Bioscience's major institutional shareholders are ARMISTICE CAPITAL, LLC, INVENOMIC CAPITAL MANAGEMENT LP, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, and RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC.. The top five shareholders own together 13.03% of the company's share outstanding.

How many Lexaria Bioscience shareholders are there?

As of Jun 2024, there are 13 institutional shareholders of Lexaria Bioscience.

What percentage of Lexaria Bioscience is owned by ARMISTICE CAPITAL, LLC?

ARMISTICE CAPITAL, LLC owns 1.02M shares of Lexaria Bioscience, representing 7.36% of the company's total shares outstanding, valued at $2.84M (as of Jun 2024).

What percentage of Lexaria Bioscience is owned by INVENOMIC CAPITAL MANAGEMENT LP?

As of Jun 2024, INVENOMIC CAPITAL MANAGEMENT LP holds 513.57K shares of Lexaria Bioscience (LEXX), compromising 3.71% of the company, valued at $1.43M.

What percentage of Lexaria Bioscience is owned by GEODE CAPITAL MANAGEMENT, LLC?

GEODE CAPITAL MANAGEMENT, LLC is the third largest holder of Lexaria Bioscience. The company owns 114.78K of the company's shares outstanding (worth $319.19K).